Lawreen H Connors

14PUBLICATIONS
21CO-AUTHORS
Immunogenetics (incl. genetic immunology)BiomaterialsMedical infection agents (incl. prions)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 22, 2023
Role of complementarity-determining regions 1 and 3 in pathologic amyloid formation by human immunoglobulin κ1 light chains.

Elena S Klimtchuk, Daniele Peterle, Esther Bullitt

|Feb 13, 2023
Role of Complementarity-Determining Regions 1 and 3 in Pathologic Amyloid Formation by Human Immunoglobulin κ1 Light Chains.

Elena S Klimtchuk, Daniele Peterle, Esther A Bullitt

|Oct 26, 2022
An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis.

Tatiana Prokaeva, Elena S Klimtchuk, Polina Feschenko

|May 16, 2022
A novel substitution of proline (P32L) destabilises β2-microglobulin inducing hereditary systemic amyloidosis.

Tatiana Prokaeva, Tracy Joshi, Elena S Klimtchuk

|Mar 07, 2022
Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays.

Michelle C Kaku, Shivkumar Bhadola, John L Berk

|Jan 27, 2022
Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience.

Omar K Siddiqi, Yuliya Y Mints, John L Berk

Pageof 3